Medicines Formulary

Reports

Drug name	NICE TAs	Comments
Copper intra-uterine devices		Second line - copper intra-uterine devices (72 – 120 hours)
Crotamiton 10% cream
Crystacide® cream
Cyclizine injection		For palliative care use
Cyclizine tablets
Daktacort cream	TA85 - Frequency of application of topical corticosteroids for atopic eczema	Mild potency
Danthron		Treatment of constipation in terminally ill patients
Dermol 500 lotion		Short term use only
Dermol 600
Desmopressin melts		Very high relative cost

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.